南美洲和中美洲测序试剂市场预测至 2028 年 - COVID-19 影响和区域分析(按技术(下一代测序、桑格测序和第三代测序)、应用(农业基因组学和法医学、临床调查、肿瘤学、生殖健康等)应用)、试剂类型(对照试剂盒、文库试剂盒、模板试剂盒、测序试剂盒和其他试剂类型)和最终用户(医院和诊所、研究机构、制药和生物技术公司和其他最终用户)

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028


No. of Pages: 143    |    Report Code: TIPRE00022832    |    Category: Life Sciences

South and Central America Sequencing Reagents Market

市场介绍

测序过程中会用到测序试剂。这些试剂的使用很大程度上取决于要获得的所需结果。它们构成了测序反应的重要组成部分,也可用于各种其他应用。

 

市场概况与动态

< p>南美洲和中美洲测序试剂市场预计将从2021年的3.428亿美元增至2028年的7.376亿美元;预计 2021 年至 2028 年复合年增长率为 11.6%。市场的增长归因于几个关键驱动因素,例如各种研究资助活动的增加和测序程序成本的下降。然而,熟练专业人员的缺乏阻碍了市场的增长。

测序是测序反应的重要组成部分,也可用于各种其他应用。现在,测序试剂越来越多地用于临床实践,在未来五年内,预计将在医疗保健领域生成来自超过 6000 万患者的基因组数据。基因组测序正在迅速转变为临床实践,医疗保健系统的实施得到了政府大量投资的支持,至少 14 个国家的投资总额超过 40 亿美元。这些国家基因组医学计划正在推动现实生活中的变革,同时解决实施障碍并收集证据以供更广泛采用,从而推动测序试剂市场的增长。此外,制造商和政府在基因组学领域的持续资助预计将在预测期内促进市场增长。近年来,二代测序价格大幅下降。由于基因组学领域的进步以及不同测序方法和策略的发展等因素,测序成本显着下降,推动了市场增长。

随着第二波COVID-19疫情的爆发,拉丁美洲国家的确诊病例不断增加。目前,巴西正在迅速增加抗击新冠病毒的临床项目。人们越来越关注基因组测序和测试。例如,2020 年 7 月,淡水河谷理工学院 (ITV) 和 Fiocruz 宣布,他们计划对 Sars-CoV-2 进行最广泛的基因组测序研究。淡水河谷在这项研究上投资了 240 万巴西雷亚尔。从长远来看,此类举措将促进南美洲和中美洲测序试剂市场的增长。

 

< span>主要细分市场

南美洲和中美洲测序试剂市场按技术分为二代测序、桑格测序和三代测序。下一代测序细分市场在 2020 年占据最大市场份额。然而,预计桑格测序细分市场在预测期内的复合年增长率最高。

南美洲和中美洲测序试剂市场按试剂类型分为对照试剂盒、文库试剂盒、模板试剂盒、测序试剂盒和其他试剂类型。测序试剂盒细分市场在 2020 年占据最大市场份额,而文库试剂盒细分市场预计在预测期内将实现最高的复合年增长率。

南方中美洲测序试剂市场按应用细分为农业基因组学和法医学、临床研究、肿瘤学、生殖健康和其他应用。肿瘤学领域在 2020 年占据最大的市场份额。然而,预计临床研究领域在预测期内的市场复合年增长率最高。

基于最终用户方面,南美洲和中美洲测序试剂市场分为医院和诊所、研究机构、制药和生物技术公司以及其他最终用户。研究机构细分市场在 2020 年占据了最大的市场份额。此外,预计该细分市场在预测期内的复合年增长率最高。

 

主要来源和列出的公司

一些与本报告有关的南美洲和中美洲测序试剂市场相关的主要和次要来源是美国临床肿瘤学会 (ASCO)、美国人类基因组学学会 (ASCG)和国际原子能机构(IAEA)。

 

原因购买报告

  • 根据详细的趋势分析确定潜在投资领域未来几年南美洲和中美洲测序试剂市场
  • 深入了解潜在因素推动支出最高的国家对不同成瘾治疗药物细分市场的需求,并确定每个细分市场提供的机会。
  • 加强您对需求驱动因素、行业趋势和最新技术发展等方面的市场了解。
  • 确定推动市场发展的主要渠道 南美洲和中美洲测序试剂市场,提供了未来机会的清晰图景,有助于分析,从而实现收入扩张。
  • 通过关注南美洲和中美洲不同国家正在进行的项目来引导资源南美洲和中美洲测序试剂市场.

 

南美洲和中美洲测序试剂市场细分

按技术

  • 下一代测序
  • 桑格测序
  • 第三代测序

按试剂类型

  • 对照试剂盒
  • 文库试剂盒
  • 模板试剂盒
  • 测序试剂盒
  • 其他试剂类型

按应用

  • 农业基因组学和法医学
  • 临床研究
  • 肿瘤学
  • 生殖健康
  • 其他应用

最终用户   

  • 医院和诊所
  • 研究机构
  • 制药和生物技术公司
  • 其他最终用户

按国家/地区

  • 巴西
  • 阿根廷
  • 休息南美洲和中美洲

公司简介

  • QIAGEN
  • Takara Bio Inc.
  • THERMO FISHER SCIENTIFIC INC.
  • TriLink BioTechnologies Inc
  • F. HOFFMANN-LA ROCHE LTD.
  • Illumina, Inc.
  • FLUIDIGM CORPORATION
  • LGC 生物搜索技术


South and Central America Sequencing Reagents Strategic Insights

Strategic insights for South and Central America Sequencing Reagents involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/south-and-central-america-sequencing-reagents-market-strategic-framework.webp
Get more information on this report

South and Central America Sequencing Reagents Report Scope

Report Attribute Details
Market size in 2021 US$ 342.80 Million
Market Size by 2028 US$ 737.60 Million
Global CAGR (2021 - 2028) 11.6%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By 技术
  • 下一代测序
  • 桑格测序
  • 第三代测序
By 应用
  • 农业基因组学和法医学
  • 临床研究
  • 肿瘤学
  • 生殖健康
  • 其他应用
By 试剂类型
  • 对照试剂盒
  • 文库试剂盒
  • 模板试剂盒
  • 测序试剂盒
  • 其他试剂类型
By 最终用户
  • 医院和诊所
  • 研究机构
  • 制药和生物技术公司
  • 其他最终用户
Regions and Countries Covered 南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
Market leaders and key company profiles
  • QIAGEN
  • Takara Bio Inc.
  • THERMO FISHER SCIENTIFIC INC.
  • TriLink BioTechnologies Inc
  • F. HOFFMANN-LA ROCHE LTD.
  • Illumina, Inc.
  • FLUIDIGM CORPORATION
  • LGC Biosearch Technologies
  • Get more information on this report

    South and Central America Sequencing Reagents Regional Insights

    The regional scope of South and Central America Sequencing Reagents refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/south-and-central-america-sequencing-reagents-market-geography.webp
    Get more information on this report

    The List of Companies - South and Central America Sequencing Reagents Market

    1. QIAGEN
    2. Takara Bio Inc.
    3. THERMO FISHER SCIENTIFIC INC.
    4. TriLink BioTechnologies Inc
    5. F. HOFFMANN-LA ROCHE LTD.
    6. Illumina, Inc.
    7. FLUIDIGM CORPORATION
    8. LGC Biosearch Technologies
    Frequently Asked Questions
    How big is the South and Central America Sequencing Reagents Market?

    The South and Central America Sequencing Reagents Market is valued at US$ 342.80 Million in 2021, it is projected to reach US$ 737.60 Million by 2028.

    What is the CAGR for South and Central America Sequencing Reagents Market by (2021 - 2028)?

    As per our report South and Central America Sequencing Reagents Market, the market size is valued at US$ 342.80 Million in 2021, projecting it to reach US$ 737.60 Million by 2028. This translates to a CAGR of approximately 11.6% during the forecast period.

    What segments are covered in this report?

    The South and Central America Sequencing Reagents Market report typically cover these key segments-

  • 技术 (下一代测序, 桑格测序, 第三代测序)
  • 应用 (农业基因组学和法医学, 临床研究, 肿瘤学, 生殖健康, 其他应用)
  • 试剂类型 (对照试剂盒, 文库试剂盒, 模板试剂盒, 测序试剂盒, 其他试剂类型)
  • What is the historic period, base year, and forecast period taken for South and Central America Sequencing Reagents Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America Sequencing Reagents Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in South and Central America Sequencing Reagents Market?

    The South and Central America Sequencing Reagents Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • QIAGEN
  • Takara Bio Inc.
  • THERMO FISHER SCIENTIFIC INC.
  • TriLink BioTechnologies Inc
  • F. HOFFMANN-LA ROCHE LTD.
  • Illumina, Inc.
  • FLUIDIGM CORPORATION
  • LGC Biosearch Technologies
  • Who should buy this report?

    The South and Central America Sequencing Reagents Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the South and Central America Sequencing Reagents Market value chain can benefit from the information contained in a comprehensive market report.